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Clinical features of asthma patients with a low %FVC.
In relation to clinical asthma type and disease severity.
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Abstract: Clinical features of asthma patients with a low %FVC «75%) were
studied in relation to clinical asthma type and disease severity. 1. The value of %FVC
was not related to patient age. 2. A significant association between %FVC value and
clinical asthma type was found. The value of %FVC was significantly lower in subjects
with type IT asthma (bronchiolar obstruction) than in those with type la-1 and type
la- 2 (simple bronchoconstriction) (p<O.OO1). 3. %FVC value significantly correlated
with disease severity. The value in the subjects tended to decrease as their asthma
conditions were more severe. 4. The %FVC value in the subjects was improved after
treatment (complex spa therapy). These results demonstrate that a significant
correlation is present between low %FVC and disease severity in asthma patients with
a low %FVC..
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Introduction
Asthma is characterized by airway hyper-
esponsiveness to a wide variety of stimuli.
When a relevant allergen IS inhaled
by asthma patients, airway narrowing devel-
ops at two different phases; within 30 min
of the inhalation (immediate asthmatic reac-
tion, IAR), and within 6 to 8 hours (late
asthmatic reaction, LAR)1-3). Airway hyper-
responisveness IS caused by reccuernt
inhalation of allergen, and the magnitude
and duration of hyperresponsiveness are
speculated to be related to the LAR 4,5) ,
which is associated with migration of inflam-
matory cells, predominantly activated
T lymphocytes and eosinophils, into the
airways 6, 7).
Symptoms of asthma, wheezing and
transient dyspnea, are closely related to such
pathophysiological changes of the airways
as bronchoconstriction, edema of mucous
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Subjects and Methods
mem brane, and hypersecretion 8 -10). These
pathophysiological changes induce aIrway
narrowing. This condition induced by
inhalation of allergen and the other stimuli
can be estimated by measuring ventilatory
function, routinely by a 20% fall in forced
expiratory volume in 1 second (FEV1.0),
which IS the most common In clinical
examination.
represents airway narrowing in patients with
asthma. Many of patients with asthma show
a predominant decrease in FEV1.0%, how-
ever, some of patients have a predominant
decrease in forced vital capacity (FVC). In
this study, clinical features of asthma
patients with low FVC were analyzed in
relation to clinical asthma type and disease
severity.
The subjects of this study were 22 asthma
patients (9 females and 13 males) with a
low %FVC under 75%. Their mean age was
60.0 years (range 23-77 years), and the age
at onset was 44.4 years (rang 3 -73 years).
The subjects were divided into 4 groups
according to the value of %FVC ; A (70 -75
%), B (60 - 69%), C (50 - 59%) and D
«50%), and 4 groups by age; 20-49, 50-
59, 60-69, and 70- years;
Asthma classification was performed
by the method previously described B, 10) ; lao
simple bronchoconstriction type, lb.
bronchoconstriction +hypersecretion type, and
II. bronchiolar obstruction type. In this
study, type la was further divided into two
subtypes according to expectoration per day;
I a- 1 (0 -49mP) and IIa- 2 (50-99mP).
Ventilatory function tests, using a Box
Spiror 81S (Chest Co) were carried out in all
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Table l. Characteristics of asthma patients
with low %FVC studied.
No of Age Age at onset IgE
%FVC patients (years) (ye.us) (IU/ml) S-Cortisol
A(70·75%) 61.4 45.3 224 5.9
(31-546) (1.7-17.5)
8(60-69%) 50.8 34.2 643 7.8
(18 I -1963) (1.0-14.0)
C(50-59%) 63.4 53.6 1180 10.6
(317-2798) (4.1 -1 6.2)
D«50%) 65.7 43.3 95 5.3
(72-108) (1.3-12.3)
20-49 50-59 60-69 70-
Age (years)
Fig. 1. Correlation between %FVC value and
age In asthma patients with low
%FVC
Results
patients when they were asymptomatic.
Table 1 shows characteristics of subjects
classified by the value of %FVC. Mean age
and age at onset were lowest in patients of
group A (%FVC ; 60 - 69%), however, any
correlation between age or age at onset and
%FVC values was not found. Serum levels of
IgE and cortisol were lower in patients of
group D (%FVC < 40%) compared to those
of group C (50-59%).
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Discussion
Bronchial inhalation challenge with allergen
causes acute bronchoconstriction and late
asthmatic reactions 1- 3). Allergen-induced
airway narrowing is usually evaluated by
a 20% fall of FEV 1.0. However, recent
studies by Gibbsons et al. demonstrate that
measure of a 20% fall in FEV1.0 during
allergen-induced asthmatic reactions does not
evaluate excessive bronchoconstriction, which
IS the most important abnormality III
these patients is reversible or not, the value
was compared before and after treatment
(complex spa therapy)lI. 12). %FVC value
tended to increase after the treatment in all
groups classified by the level of %FVC. A
significant increase in %FVC after the treat-
ment was found in patients with the value
between 70 and 75% (p<O.OOl), and in those
under 49% (p<0.05) (Fig. 4).
slight Moderate Severe
Asthma severity
Fig. 3. Correlation between %FVC value and
asthma severity in patients with
low %FVC. a, p<O.01.
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Fig. 2. Correlation between %FVC value and
clinical asthma type in patients
with low %FVC. a and b, p<O.OO1.
The value of %FVC correlated with asthma
severity in patients with low %FVC. The
value tended to more decrease as asthma
conditions were more severe. The value was
55.3% in patients with severe asthma and
70.3% in those with slight asthma. This
difference was significant (p<O.Ol) (Fig. 3).
To assess whether a low %FVC value in
The mean value of %FVC was 65.3 ±4.7%
in patients between the ages of 20 and 49,
61.9±9.1% in those between 50 and 59, 61.9
± 10.5% in those between 60 and 69, and 62.
1± 15.3% in those over age 70. There was no
significant difference among four age groups
(Fig. 1).
A correlation between %FVC value and
clinical asthma type was recognized. The
%FVC value was significantly lower in
patients with type IT asthma than in those
with type la - 1 (p<O.OOl) and type la - 2
(p<O.OOl). The value in type lb (59.0%) was
lower than that in those with type la - 2
(67.5%), however, this was not significant
(Fig. 2).
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Fig. 4. Improvement of %FVC in asthma
patients with low %FVC after
treatment (complex spa therapy).
The value before treatment (G)
significantly increased after the
therapy (e).
a, p<O.OOl, b, p<0.05.
asthma, Slllce it puts patients at risk
for serious illness l3l . They recommend that
measuring %fall in FVC when FEV1.0 falls
by 20% is a safe mothod of detecting
excessive bronchoconstriction.
When airway smooth muscle contraction
produces unlimited bronchoconstriction to
the extent that airway closure occurs, this
results in an increase in residual volume
(RV) with a corresponding decrease in vital
capacity (VC). It has been shown that RV
increasesl~15) and VC falls l6) significantly in
asthma patients during allergen-induced
bronchoconstriction.
In this study, association between decrease
in %FVC and disease severity was examined
in asthma patients whose %FVC was under
75%. A decrease in %FVC was not related to
patient age, suggesting that decrease in
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肺活量 (FVC)低値を示す気管支瑞息の臨床的
特徴
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岡山大学医学部附属病院三朝分院内科, 1)医学部
臨床検査医学
%肺活量が75%以下の低値を示す気管支瑞息に
ついて,その臨床的特徴を,臨床病型や重症度と
の関連のもとに検討した｡
1.%肺活量と年齢との間には関連は見られなかっ
た｡
2.%肺活量と臨床病型との問には有意の関連が
13
見られ,Ⅲ型喋息 (細気管支閉塞塑)における
%肺活量は,Ia-1型やIa-2型などの単純
性気管支撃縮型に比べ,有意に低い値を示した｡
3.%肺活量はまた喋息の重症度と有意の関連を
示した｡これらの症例では,瑞息の重症度が増
すにつれて,%肺活量は減少する傾向が見られ
た ｡
4.これら症例の低値を示す%肺活量は,治療
(複合温泉療法)により改善される傾向が見ら
れた｡
以上の結果より,これらの症例 (%肺活量が75
%以下)では,%肺活量と暗息の重症度との間に
ある程度の関連があることが明らかになった｡
索引用語 :%FVC低値,気管支喋息,臨床病型,
重症度,温泉療法
